article thumbnail

Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission

TechCrunch

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265
article thumbnail

Sequoia India’s Surge backs healthtech startup RedBrick AI in $4.6M funding

TechCrunch

For annotating complex 3D medical images, it also has semi-automated tools. Image Credits: RedBrick AI additionally provides APIs that machine learning engineers can integrate with their cloud solutions and clinical data stores, including hospital enterprise PACS servers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round

TechCrunch

The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. “This is done most easily when one knows how exactly these drugs bind to the protein (the exact 3D shape of the ligand bound to the disease-causing protein). All it takes is one hit and they’re laughing.

article thumbnail

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

TechCrunch

The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. A rotating 3D model of an RNA strand structure predicted by PARSE. And combined with other machine learning work, we have been able to dramatically improve both the speed and accuracy from the paper.”

article thumbnail

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

TechCrunch

Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and eventually transplant.

System 203
article thumbnail

Meet the 14 companies launching out of the Entrepreneurs Roundtable Accelerator

TechCrunch

Andiamo uses machine learning, 3D simulation and 3D printing to create custome braces for children with cerebral palsy, bringing down the cost and improving outcomes for clinicians, patients and families alike. So without any further ado, here are the startups graduating out of the summer 2021 ERA class. departments.

Company 208
article thumbnail

AI in Drug Discovery and Repurposing: Benefits, Approaches, and Use Cases

Altexsoft

So, it comes as no surprise that all large biopharma companies are investing in AI, particularly in deep learning , which has the potential to make the hunt for drugs cheaper, faster, and more precise. It’s worth noting that regulatory bodies treat the use of machine learning in healthcare with caution. Source: Deloitte.